Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 5.07
-0.07 (-1.36%)
Jul 31, 2026, 3:29 PM IST
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 421.2 million as of July 31, 2026. Its market cap has increased by 2.63% in one year.
Market Cap
421.20M
Enterprise Value
4.38B
Revenue
763.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.07
ChartMarket Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 421.20M, a decrease of -59.50%. That is a compound annual growth rate of -4.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 421.20M | -71.25% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.56B |
| Sigachi Industries | 9.91B |
| Bafna Pharmaceuticals | 6.10B |
| Valiant Laboratories | 3.35B |
| Nectar Lifesciences | 1.99B |
| Brooks Laboratories | 1.76B |
| Alpa Laboratories | 1.42B |
| Balaxi Pharmaceuticals | 1.33B |